125699003: Samarium (153-Sm) lexidronam (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Antineoplastic agent (substance)\Samarium (153-Sm) lexidronam (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Metal and/or metal compound\Samarium and/or samarium compound\Samarium radioisotope\Samarium-153 (substance)\Samarium (153-Sm) lexidronam (substance)

\Inorganic chemical\Isotope\Radioactive isotope\Samarium radioisotope\Samarium-153 (substance)\Samarium (153-Sm) lexidronam (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3649129010 Samarium (153-Sm) lexidronam (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

3649130017 Samarium (153-Sm) lexidronam en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Samarium (153-Sm) lexidronam (substance)	Is a	Radioisotopic compound for diagnosis AND/OR treatment	false	Inferred relationship	Some
Samarium (153-Sm) lexidronam (substance)	Is a	Medicinal product acting as antineoplastic agent (product)	false	Inferred relationship	Some
Samarium (153-Sm) lexidronam (substance)	Is a	Antineoplastic agent (substance)	true	Inferred relationship	Some
Samarium (153-Sm) lexidronam (substance)	Is a	Samarium-153 (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing samarium (153-Sm) lexidronam (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Samarium (153-Sm) lexidronam (substance)	Inferred relationship	Some	1
Samarium SM 153 lexidronam injection solution 3mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Samarium (153-Sm) lexidronam (substance)	Inferred relationship	Some
Intravenous radionuclide therapy using samarium Sm 153 lexidronam (procedure)	Direct substance	False	Samarium (153-Sm) lexidronam (substance)	Inferred relationship	Some	3
Product containing only samarium (153-Sm) lexidronam (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Samarium (153-Sm) lexidronam (substance)	Inferred relationship	Some	1
Samarium (153-Sm) lexidronam pentasodium	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Samarium (153-Sm) lexidronam (substance)	Inferred relationship	Some
Product containing samarium (153-Sm) lexidronam in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Samarium (153-Sm) lexidronam (substance)	Inferred relationship	Some	1
Samarium (153-Sm) lexidronam only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Samarium (153-Sm) lexidronam (substance)	Inferred relationship	Some	1
Intravenous radionuclide therapy using samarium Sm 153 lexidronam (procedure)	Direct substance	True	Samarium (153-Sm) lexidronam (substance)	Inferred relationship	Some	1
Intravenous radionuclide therapy using samarium Sm 153 lexidronam (procedure)	Using substance (attribute)	True	Samarium (153-Sm) lexidronam (substance)	Inferred relationship	Some	2

This concept is not in any reference sets